{
  "image_filename": "figure_p1_det_0_003.png",
  "image_path": "CDC_Influenza_vaccines/extracted/figures/figure_p1_det_0_003.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_003",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A tabular listing of influenza vaccines for the United States 2023\u201324 season, including trade names, manufacturers, presentations (e.g., 0.5-mL prefilled syringe, multi-dose vial), age indications, hemagglutinin content per dose, route of administration, and mercury (thimerosal) content. The table does not mention vaccine production mutations, egg adaptations, or any impact on effectiveness; it only provides dosing and formulation details, so it does not support the claim.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A tabular listing of influenza vaccines for the United States 2023\u201324 season, including trade names, manufacturers, presentations (e.g., 0.5-mL prefilled syringe, multi-dose vial), age indications, hemagglutinin content per dose, route of administration, and mercury (thimerosal) content.",
    "evidence_found": null,
    "reasoning": "The table does not mention vaccine production mutations, egg adaptations, or any impact on effectiveness; it only provides dosing and formulation details, so it does not support the claim.",
    "confidence_notes": null
  }
}